Activist Investor 13D, 13G Filings


This page shows a list of all the recent 13D/G filings made by Schuler Jack W. Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

DateForm Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2017‑11‑09 SC 13D/A BIOL / Biolase, Inc. 22,572,152 22,572,152 0.00 28.69 -0.07
2017‑09‑05 SC 13D/A VRML / Vermillion, Inc. 11,511,898 11,511,898 0.00 19.1 -2.55
2017‑07‑06 SC 13D/A BIOL / Biolase, Inc. 22,572,152 22,572,152 0.00 28.71 0.00
2017‑07‑05 SC 13D/A BIOL / Biolase, Inc. 20,728,060 22,572,152 8.90 28.71 0.00
2017‑04‑17 SC 13D/A BIOL / Biolase, Inc. 17,029,460 20,728,060 21.72 28.71 15.35
2017‑02‑17 SC 13D/A VRML / Vermillion, Inc. 9,499,679 11,511,898 21.18 19.6 8.89
2017‑02‑14 SC 13G/A NEOS / Neos Therapeutics, Inc. 1,091,652 1,831,616 67.78 11.4 67.65
2016‑10‑04 SC 13D/A BIOL / Biolase, Inc. 16,144,902 17,029,460 5.48 24.89 -4.49
2016‑08‑03 SC 13D/A BIOL / Biolase, Inc. 11,935,138 16,144,902 35.27 26.06 27.12
2016‑02‑25 SC 13D/A AXDX / Accelerate Diagnostics, Inc. 13,311,091 14,106,565 5.98 27.5 5.77
2016‑02‑11 SC 13G NEOS / Neos Therapeutics, Inc. 1,091,652 6.8
2016‑02‑11 SC 13D/A TTHI / Transition Therapeutics Inc. 6,175,540 18.8
2016‑01‑20 SC 13D/A GTXO / GTX Corp. 12,246,208 8.72
2015‑12‑29 SC 13D/A AXDX / Accelerate Diagnostics, Inc. 13,311,091 26.0
2015‑12‑14 SC 13D/A BIOL / Biolase, Inc. 11,711,416 11,935,138 1.91 20.5 2.55
2015‑11‑13 SC 13D/A BIOL / Biolase, Inc. 11,711,416 11,711,416 0.00 19.99 0.00
2015‑11‑09 SC 13D/A BIOL / Biolase, Inc. 11,894,624 11,711,416 -1.54 19.99 0.00
2015‑10‑23 SC 13D/A BIOL / Biolase, Inc. 12,078,598 11,894,624 -1.52 19.99 0.00
2015‑10‑14 SC 13D/A BIOL / Biolase, Inc. 12,078,598 19.99
2015‑07‑21 SC 13D/A VRML / Vermillion, Inc. 8,734,371 9,499,679 8.76 18.0 -9.55
2015‑06‑23 SC 13D/A MBLX / Metabolix, Inc. 14,966,507 50.0
2015‑05‑20 SC 13D/A HNSN / Hansen Medical, Inc. 75,074,576 35.14
2015‑04‑28 SC 13D/A VRML / Vermillion, Inc. 8,734,371 19.9
2015‑03‑26 SC 13D/A HNSN / Hansen Medical, Inc. 28,078,963 19.99
2015‑03‑23 SC 13D/A VRML / Vermillion, Inc. 7,961,368 18.5
2015‑03‑06 SC 13D/A BIOL / Biolase, Inc. 12,311,883 19.9